Tumor-platelet interactions: Glioblastoma growth is accompanied by increasing platelet counts

Clinical Neurology and Neurosurgery

Volumn 110, Issue 4, 2008, Pages 339-342

  Nolte, Ingo ^a   Przibylla, Heike ^a   Bostel, Tilman ^a   Groden, Christoph ^a   Brockmann, Marc A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Glioblastoma; Malignant glioma; Platelets; Thrombocytosis

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; GLIOBLASTOMA; HUMAN; PREOPERATIVE EVALUATION; THROMBOCYTE COUNT; THROMBOCYTOSIS; TISSUE INTERACTION; TUMOR GROWTH;

BRAIN NEOPLASMS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; PLATELET COUNT; PROGNOSIS; REFERENCE VALUES; SURVIVAL ANALYSIS; THROMBOCYTOSIS;

EID: 41149103329     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2007.12.008     Document Type: Article

References (48)

1. Brockmann M.A., Giese A., Mueller K., Kaba F.J., Lohr F., Weiss C., et al. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma. Neuro Oncol 9 (2007) 335-342
2. Pinedo H.M., Verheul H.M., D'Amato R.J., and Folkman J. Involvement of platelets in tumour angiogenesis?. Lancet 352 (1998) 1775-1777
3. Fernandez-Patron C., Martinez-Cuesta M.A., Salas E., Sawicki G., Wozniak M., Radomski M.W., et al. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost 82 (1999) 1730-1735
4. Jurasz P., Chung A.W., Radomski A., and Radomski M.W. Nonremodeling properties of matrix metalloproteinases: the platelet connection. Circ Res 90 (2002) 1041-1043
5. Wartiovaara U., Salven P., Mikkola H., Lassila R., Kaukonen J., Joukov V., et al. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 80 (1998) 171-175
6. Mohle R., Green D., Moore M.A., Nachman R.L., and Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A 94 (1997) 663-668
7. Heldin C.H., Westermark B., and Wasteson A. Platelet-derived growth factor. Isolation by a large-scale procedure and analysis of subunit composition. Biochem J 193 (1981) 907-913
8. Kaplan D.R., Chao F.C., Stiles C.D., Antoniades H.N., and Scher C.D. Platelet alpha granules contain a growth factor for fibroblasts. Blood 53 (1979) 1043-1052
9. Ben-Ezra J., Sheibani K., Hwang D.L., and Lev-Ran A. Megakaryocyte synthesis is the source of epidermal growth factor in human platelets. Am J Pathol 137 (1990) 755-759
10. Suzuki A., Takahashi T., Nakamura K., Tsuyuoka R., Okuno Y., Enomoto T., et al. Thrombocytosis in patients with tumors producing colony-stimulating factor. Blood 80 (1992) 2052-2059
11. Karey K.P., and Sirbasku D.A. Human platelet-derived mitogens. II. Subcellular localization of insulinlike growth factor I to the alpha-granule and release in response to thrombin. Blood 74 (1989) 1093-1100
12. White R.R., Shan S., Rusconi C.P., Shetty G., Dewhirst M.W., Kontos C.D., et al. Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc Natl Acad Sci U S A 100 (2003) 5028-5033
13. English D., Welch Z., Kovala A.T., Harvey K., Volpert O.V., Brindley D.N., et al. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J 14 (2000) 2255-2265
14. Hla T. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 15 (2004) 513-520
15. Galt S.W., Lindemann S., Allen L., Medd D.J., Falk J.M., McIntyre T.M., et al. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res 90 (2002) 1093-1099
16. Iruela-Arispe M.L., Bornstein P., and Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci U S A 88 (1991) 5026-5030
17. Savage B., Saldivar E., and Ruggeri Z.M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84 (1996) 289-297
18. Maione T.E., Gray G.S., Petro J., Hunt A.J., Donner A.L., Bauer S.I., et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247 (1990) 77-79
19. Booth N.A., Simpson A.J., Croll A., Bennett B., and MacGregor I.R. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 70 (1988) 327-333
20. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79 (1994) 315-328
21. Kisucka J., Butterfield C.E., Duda D.G., Eichenberger S.C., Saffaripour S., Ware J., et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A 103 (2006) 855-860
22. Herndon J.E., Green M.R., Chahinian A.P., Corson J.M., Suzuki Y., and Vogelzang N.J. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113 (1998) 723-731
23. Engan T., and Hannisdal E. Blood analyses as prognostic factors in primary lung cancer. Acta Oncol 29 (1990) 151-154
24. Pedersen L.M., and Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9 (1996) 1826-1830
25. Costantini V., Zacharski L.R., Moritz T.E., and Edwards R.L. The platelet count in carcinoma of the lung and colon. Thromb Haemost 64 (1990) 501-505
26. Silvis S.E., Turkbas N., and Doscherholmen A. Thrombocytosis in patients with lung cancer. JAMA 211 (1970) 1852-1853
27. O'Keefe S.C., Marshall F.F., Issa M.M., Harmon M.P., and Petros J.A. Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol 168 (2002) 1378-1380
28. Symbas N.P., Townsend M.F., El-Galley R., Keane T.E., Graham S.D., and Petros J.A. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int 86 (2000) 203-207
29. Monreal M., Fernandez-Llamazares J., Pinol M., Julian J.F., Broggi M., Escola D., et al. Platelet count and survival in patients with colorectal cancer-a preliminary study. Thromb Haemost 79 (1998) 916-918
30. Hernandez E., Lavine M., Dunton C.J., Gracely E., and Parker J. Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer 69 (1992) 2975-2977
31. Hernandez E., Donohue K.A., Anderson L.L., Heller P.B., and Stehman F.B. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 78 (2000) 137-142
32. Chalas E., Welshinger M., Engellener W., Chumas J., Barbieri R., and Mann W.J. The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am J Obstet Gynecol 166 (1992) 974-977
33. Zeimet A.G., Marth C., Muller-Holzner E., Daxenbichler G., and Dapunt O. Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 170 (1994) 549-554
34. Taucher S., Salat A., Gnant M., Kwasny W., Mlineritsch B., Menzel R.C., et al. Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 89 (2003) 1098-1106
35. Hefler L., Mayerhofer K., Leibman B., Obermair A., Reinthaller A., Kainz C., et al. Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol 21 (2000) 309-314
36. Van Meir E., Sawamura Y., Diserens A.C., Hamou M.F., and de Tribolet N. Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 50 (1990) 6683-6688
37. Dubost J.J., Rolhion C., Tchirkov A., Bertrand S., Chassagne J., Dosgilbert A., et al. Interleukin-6-producing cells in a human glioblastoma cell line are not affected by ionizing radiation. J Neurooncol 56 (2002) 29-34
38. Chang C.Y., Li M.C., Liao S.L., Huang Y.L., Shen C.C., and Pan H.C. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme. J Clin Neurosci 12 (2005) 930-933
39. Hollen C.W., Henthorn J., Koziol J.A., and Burstein S.A. Serum interleukin-6 levels in patients with thrombocytosis. Leuk Lymphoma 8 (1992) 235-241
40. Kuyama J., Take H., Matsumoto S., Nakajima T., Sugase T., Hata A., et al. Synchronous fluctuation of interleukin-6 and platelet count in cyclic thrombocytopenia and thrombocytosis. Intern Med 34 (1995) 636-639
41. Loeffler S., Fayard B., Weis J., and Weissenberger J. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer 115 (2005) 202-213
42. Gauthier T., Hamou M.F., Monod L., Gallay P., Carrel S., and de Tribolet N. Expression and release of interleukin-1 by human glioblastoma cells in vitro and in vivo. Acta Neurochir (Wien) 121 (1993) 199-205
43. Cinque S., Willems J., Depraetere S., Vermeire L., and Joniau M. In vitro" effect of interleukin-1 beta on human glioma cell lines: regulation of cell proliferation and IL-6 production. Immunol Lett 34 (1992) 267-271
44. Mueller M.M., Herold-Mende C.C., Riede D., Lange M., Steiner H.H., and Fusenig N.E. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol 155 (1999) 1557-1567
45. Benoy I., Salgado R., Colpaert C., Weytjens R., Vermeulen P.B., and Dirix L.Y. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer 2 (2002) 311-315
46. Sierko E., and Wojtukiewicz M.Z. Platelets and angiogenesis in malignancy. Semin Thromb Hemost 30 (2004) 95-108
47. Trikha M., and Nakada M.T. Platelets and cancer: implications for antiangiogenic therapy. Semin Thromb Hemost 28 (2002) 39-44
48. Manegold P.C., Hutter J., Pahernik S.A., Messmer K., and Dellian M. Platelet-endothelial interaction in tumor angiogenesis and microcirculation. Blood 101 (2003) 1970-1976